Antihemophilic Factor Articles
Bayer's income reaches 1.59B in 2005, up 133%
13 March 2006
Viragen's Multiferon approved in Sweden
27 February 2006
Pharming NV sees 2005 losses of 17.9 M
27 February 2006
Stock Commentary - New York week to Feb 13, 2006
20 February 2006
Baxter/Halozyme see good data on SubQ plus Hylenex
20 February 2006
Targeted Genetics boosts AAV vector IP
20 February 2006
US FDA accepts Merck's Gardasil BLA
13 February 2006
Merck & Co's Rotateq gets FDA OK
13 February 2006
Pharming enters $30M HAE drug accord
13 February 2006
Merck & Co's Gardasil BLA "on track"
13 February 2006
Biovitrum licenses Symphogen's Sym001 for blood disorders
6 February 2006
FDA approves Pfizer's Exubera inhaled insulin
6 February 2006
CHMP gives nod to Sandoz' Omnitrope
6 February 2006
Lilly swings to 4th-qtr 2005 profit
6 February 2006
Serono's Gonal-f approved in Japan
30 January 2006
Tercica sells 5M shares to raise $30M
30 January 2006
Biovitrum and Syntonix sign factor IX accord
30 January 2006
Bayer releases Kognate reconstitution system
30 January 2006
Bayer to pay up to $385M for ex-US sale rights to Nuvelo's Ph III thrombolytic, alfimeprase
16 January 2006
Symphogen attracts $25M investment for polyclonal Ab trials
16 January 2006
Serono r-hGH meets all Ph III endpoints
16 January 2006
Morphosys and Chemicon to develop Ab drugs
16 January 2006
Serono's r-hGH performs well in HARS study
16 January 2006
Tercica launches Increlex in USA
9 January 2006
Pharming completes rhC1INH compassionate-use filings
9 January 2006
Sanofi Pasteur MSD to submit MAA to EMEA for Gardasil
19 December 2005
Roche and Maxygen sign Factor VIII development accord
19 December 2005
Dyax start Ph III trials of angiodema drug
19 December 2005
Halozyme/Baxter get FDA appro for Hylenex
12 December 2005
Peregrine unit begins first commercial-stage project
12 December 2005
Stock Commentary - Europe - week to Dec 5
12 December 2005
Generex's Oral-lyn gains approval in Ecuador
12 December 2005
Merck & Co files BLA for Gardasil with US FDA
12 December 2005
Alizyme to start ATL-104 mucositis trial
5 December 2005
Avidis licenses aXent to Merial
5 December 2005
Bayer's Kogenate gets FDA approval
5 December 2005
Viragen's Multiferon promising in H5N1 trial
5 December 2005
Novartis suit seeks FDA ruling on follow-on HGH
19 September 2005
Nuvelo begins Alfimeprase Ph III trials
12 September 2005
Pharming's fibrinogen used for Army R&D
12 September 2005
Stock Commentary - Tokyo week to Aug 15
5 September 2005
Japan stock market two week to August 29
5 September 2005
Sanofi ups guidance as 2nd-qtr EPS rises 24.7%
5 September 2005
Novo Nordisk restructures R&D
22 August 2005
Crucell enters two new collaborations
22 August 2005
Halozyme gets US OK for Chemophase trial
22 August 2005
Novo Nordisk's first-half sales rise 15%
22 August 2005
Organon's Follistim launched in Japan
15 August 2005
Complex result in Forteo vs Fosamax trial
15 August 2005
GTC Biotech sees potential for antithrombin Ab
15 August 2005
Acambis embarks on universal influenza vaccine R&D program
15 August 2005
Halozyme/Baxter sign EU Hylenex deal
15 August 2005
Cilag gains European nesiritide rights
8 August 2005
Biolex to acquire LemnaGene
1 August 2005
Protalix raises $5.3M in private financing
25 July 2005
FDA accepts NPS' NDA for Preos
25 July 2005
Crucell to begin MAb clinical trials for rabies
25 July 2005
Cytheris starts two Phase I trial of HIV drug
18 July 2005
LSBC and Planet expand biomanufacturing program
18 July 2005
Amgen's Aranesp gives 77% response in MDS
18 July 2005
Pharming due first milestone from Esteve
18 July 2005
Halozyme submits IND for Chemophase
11 July 2005
No allergic reactions from Halozyme's rHuPH20
4 July 2005
Geron refines hESC culture protocol
4 July 2005
Repligen's FY 2005 sees 35% sales rise
6 June 2005
Halozyme's Hylenex NDA accepted by FDA
6 June 2005
Rincon and Biogen Idec form research alliance
30 May 2005
UCB/Lonza supply deal
23 May 2005
Savient's Puricase looking good in gout
23 May 2005
Halozyme reduces IOP in animals
16 May 2005
Novo Nordisk sales up 11%, EPS rises 19%
16 May 2005
Amgen submits sBLA for Aranesp
16 May 2005
Priority review for Tercica's growth agent
9 May 2005
Halozyme's hyaluronidase enhances chemotherapy
28 April 2005
SynCo BioPartners upgrades production unit
27 April 2005
UK Queen's Award for Delta Biotech
25 April 2005
VaxGen secures space for Anthrax vacc production
25 April 2005
Viragen's Multiferon cleared in Philippines
25 April 2005
AEterna signs research deal with German univ
25 April 2005
Halozyme receives US clearance for Cumulase
25 April 2005
Former Serono executives indicted for kickbacks
25 April 2005
Baxter sees 8% sales growth in 1st qtr
22 April 2005
Panbio purchases Corixa's research on tick diseases
18 April 2005
Bayer Healthcare looks set to expand in Japan
18 April 2005
Ferring debuts new fertility treatment in USA
18 April 2005
Halozyme and Baxter expand Enhanze deal
18 April 2005
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
